Microsoft word - press release - antitrust expansion 083110.doc

Media Contact: Elise Martin, 302-622-7004, [email protected] Grant & Eisenhofer Boosts Antitrust Practice with Addition
of Linda Nussbaum and John Radice
New Attorneys Strengthen Firm’s Antitrust Practice Group ------------------------------------------------------------------------------------------------------------------------------- NEW YORK (August 31, 2010) – Leading securities and corporate governance law firm, Grant & Eisenhofer P.A., today announced that it has expanded its Antitrust practice with the appointment of Linda P. Nussbaum as a Director and John D. Radice as a Senior Counsel. They will be based in the firm’s New York office. “The top-level antitrust expertise that Linda and John bring to the firm significantly enhances the existing practice group and will be a tremendous asset to our clients,” said Jay Eisenhofer, managing director and co-founder of Grant & Eisenhofer. Grant & Eisenhofer broadened its practice groups to include antitrust litigation in June of this year. “Together, Linda and John bring decades of successful experience in class and individual antitrust litigation, particularly in the pharmaceutical field,” said Stuart Grant, the firm’s managing director and co-founder. “As we continue to expand our complex litigation offerings, Linda and John are a terrific addition to our antitrust group.” Susan R. Schwaiger, an antitrust attorney with nearly two decades of experience, also will be joining the firm as associate. Ms. Schwaiger previously was Of Counsel with several leading New York-based antitrust firms representing plaintiffs in class and individual actions.
Linda P. Nussbaum

Linda Nussbaum’s practice focuses on plaintiff’s antitrust litigation in both class and individual actions. Ms. Nussbaum has served as sole or co-lead counsel in many significant antitrust class actions which have resulted in substantial recoveries, many in the realm of hundreds of millions of dollars. Ms. Nussbaum recently conducted a five-week jury trial on behalf of Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals in Boston before Justice Saris resulting in a RICO verdict against Pfizer of $47 million before trebling. Ms. Nussbaum presently serves in a lead counsel position in: In re Puerto Rican Cabotage Antitrust Litigation; In re DDAVP Direct Purchaser Antitrust Litigation; In re Wellbutrin XL Antitrust Litigation; Meijer, Inc., et al. v. Astrazeneca Pharmaceuticals Lp, et al (Torprol Direct Purchaser Antitrust Litigation; In re Miralax Direct Purchaser Antitrust Litigation and Meijer, Inc., et al. v. Abbott Laboratories (Norvir Direct Purchaser Antitrust Litigation). In addition, Ms. Nussbaum represents large corporate entities in individual actions in In re Payment Card Interchange Fee and Merchant Discount Antitrust Litigation, Case No. 1:05-md- 1720 (JG) (JO) (E.D.N.Y.); In re Neurontin Marketing and Sales Practices Litigation, Master File No. 04-10981 (PBS) MDL Docket No. 1629 (D. Mass.); In re Chocolate Confectionary Antitrust Litigation, Case No. 1:08-md-1935 (CCC) (M.D.Pa.); and CVS Pharmacy v. American Express Travel Related Services, et al., Case No. 08-cv-2316 (NGG) (E.D.N.Y.). Ms. Nussbaum is admitted to practice in New York and DC, as well as various district courts and the Supreme Court of the United States. Ms. Nussbaum earned her law degree from George Washington University in 1977 and her LL.M in Taxation from New York University School of Law in 1984. She graduated with honors from Brooklyn College in 1974.
John D. Radice
John D. Radice practices in the areas of antitrust, False Claims Act, and other areas of complex civil litigation. Representative cases include: In re Tricor Direct Purchaser Antitrust Litig., In re Neurontin Marketing & Sales Litig., United States ex rel. Piacentile v. Bristol-Myers Squibb Co., United States ex rel. Marchese v. Cell Therapeutics, Inc.,. Prior to joining the firm, Mr. Radice was associated with major plaintiffs’ class action firms in New York and Philadelphia, where he primarily represented clients pursuing antitrust, False Claims Act, and international human rights cases. Mr. Radice is admitted to practice in New York and New Jersey, as well as various district courts. Mr. Radice clerked for Judge Edith Brown Clement in the United States Court of Appeals for the Fifth Circuit in New Orleans following his graduation from New York University School of Law in 2003. He graduated magna cum laude from Princeton University in 1997.
Note: In addition to its antitrust practice, Grant & Eisenhofer P.A. represents institutional investors, both
domestic and foreign, in securities class actions, corporate governance actions and derivative litigation. The
firm has recovered approximately $12 billion for shareholders in the last five years and was cited by
RiskMetrics for securing the highest average investor recovery in securities class actions of any U.S. law
firm in 2008. Grant & Eisenhofer has also been named one of the country’s top plaintiffs’ law firms by the
National Law Journal for the past four years. For more information, visit


Diabetes medication table (shssr march 2013)

SHSSR Diabetes Oral and Non-Insulin Injectable Medication Overview Revision 5.17.2013 References OnlineTM, Pediatric Lexi-Drugs OnlineTM , Hudson, Ohio: Lexi-Comp, Inc.; Facts & Comparisons. Facts & Comparisons Web site. Clinical Pharmacology Web site. Pharmacist’s Letter. Drugs

Summer registration form

The Clubhouse - School-Age Care Summer Day Camp School District of Amery • 715-268-9771 x220 • 555 Minneapolis Ave, Amery, WI 54001 • New Clubhouse Family Returning Clubhouse Family Parent/Guardian 1 • 469 Minneapolis Ave • Amery, WI 54001 Parent/Guardian 2 Relationship to child(ren) E-mail ion fee to A Children (enroll all children

Copyright © 2010-2014 Medical Articles